Groupe la Francaise’s Astria Therapeutics ATXS Stock Holding History

Groupe la Francaise’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-108,800	Closed	-$1.42M	–	457
2025 Q4	$1.42M	Buy	+108,800	New	+$1.3M	0.02%	263

Groupe la Francaise's ATXS Position: Q1 2026 in Review

Groupe la Francaise sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 108,800 shares — an estimated $1.42M sold.

Groupe la Francaise first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $1.42M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Groupe la Francaise reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Groupe la Francaise sold 108,800 Astria Therapeutics shares in Q1 2026, an estimated $1.42M.
Groupe la Francaise first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Groupe la Francaise's Astria Therapeutics position peaked at $1.42M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.